Literature DB >> 9529763

Medical consultation for migraine: results from the American Migraine Study.

R B Lipton1, W F Stewart, D Simon.   

Abstract

BACKGROUND: Migraine headaches are often disabling but usually responsive to treatment. Nonetheless, many people with migraine never consult a doctor for headaches. In a sample of the US population, we sought to determine the proportion of active migraineurs who ever consulted a doctor for headache and to identify the headache characteristics and sociodemographic factors associated with consulting.
METHOD: A mailed questionnaire survey was sent to 15,000 US households, selected from a panel to be representative of the US population. Of 20,468 eligible respondents ranging in age from 12 to 80 years, 2479 met a case definition for migraine. We mailed a second questionnaire to all migraineurs identified on the first survey and achieved a 69.4% response rate. The second survey assessed headache characteristics, patterns of medical care use, medication use, and method of payment for health care.
RESULTS: Sixty-eight percent of female and 57% of male migraineurs reported having ever consulted a doctor for headache. Consultation was more likely with increasing age and in women who ever married. In females, several headache characteristics including pain intensity, number of migraine symptoms, attack duration, and disability were associated with consultation. Of those who never consult, 61% report severe or very severe pain and 67% report severe disability or the need for bed rest with their headaches.
CONCLUSION: The results of this survey indicate that a significant proportion of migraine sufferers never consult doctors for their headaches. Given that a large proportion of persons who never consult report high levels of pain and disability, these data suggest that there are opportunities to appropriately increase health care utilization for migraine. Given that 40% of migraineurs who have ever consulted do not report a physician diagnosis of migraine, there is a need to improve headache diagnosis and/or doctor-patient communication about migraine.

Entities:  

Mesh:

Year:  1998        PMID: 9529763     DOI: 10.1046/j.1526-4610.1998.3802087.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  69 in total

Review 1.  Prophylactic migraine therapy: emerging treatment options.

Authors:  Marcelo E Bigal; Abouch V Krymchantowski; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2004-06

2.  Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.

Authors:  Hans-Christoph Diener; Stefan Evers
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

3.  Migraine with aura white matter lesions: preliminary data on clinical aspects.

Authors:  Alberto Galli; P Di Fiore; G D'Arrigo; C Uggetti; S Squarza; M Leone; D D'Amico; F Frediani
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 4.  Headache and Barometric Pressure: a Narrative Review.

Authors:  Kushagra Maini; Nathaniel M Schuster
Journal:  Curr Pain Headache Rep       Date:  2019-11-09

5.  Acute Treatment of Migraine Headache.

Authors:  Marcelo E. Bigal; Richard B. Lipton
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

6.  In-office discussions of migraine: results from the American Migraine Communication Study.

Authors:  Richard B Lipton; Steven R Hahn; Roger K Cady; Jan Lewis Brandes; Suzanne E Simons; Philip A Bain; Meaghan R Nelson
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

7.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

8.  Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions.

Authors:  Diane M Turner-Bowker; Martha S Bayliss; John E Ware; Mark Kosinski
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

9.  Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

Authors:  Kenneth A Holroyd; Constance K Cottrell; Francis J O'Donnell; Gary E Cordingley; Jana B Drew; Bruce W Carlson; Lina Himawan
Journal:  BMJ       Date:  2010-09-29

10.  Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update.

Authors:  Sergio Carmona; Osvaldo Bruera
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.